Paper Review Records
全部论文审稿周期
30 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
26
天
31
天
Pain Severity Trajectories and Patient Profiles in Chronic Pain Patients Treated with Cannabis‐Based Medicinal Products: A k‐Means Clustering Analysis of the UK Medical Cannabis Registry
作者
Simon Erridge; Aritra Datta; Aditya Mukherjee; Dhruv Vasooja; Ross Coomber; Sushil Beri; Shaheen A. Khan; Mark W. Weatherall; Michael W. Platt; James J. Rucker; Pedro A. M. Mediano; Mikael H. Sodergren展开收起
作者单位
1. Medical Cannabis Research Group Department of Surgery and Cancer Imperial College London London UK; 2. Curaleaf Clinic Curaleaf International London UK; 3. St. George's Hospital London UK; 4. Imperial College Healthcare NHS Trust London UK; 5. Guy's and St. Thomas' NHS Foundation Trust London UK; 6. Buckinghamshire Healthcare NHS Trust Amersham UK; 7. Department of Psychological Medicine King's College London London UK; 8. South London and Maudsley NHS Foundation Trust London UK; 9. Department of Computing Imperial College London London UK展开收起
64
天
Fostering Clinical Pharmacology and Drug Development in India: A Perspective From SAC‐ACCP
作者
Karthik Venkatakrishnan; Abhigyan Ravula; Sagar Bachhav; Mohammad Faruq; Bratati Kahali; AVS Suresh; Sanish Davis; Manish Lavhale; Amruta Gadade; Gurusharan Dumra; Vikas Dighe; Vipin Dhote; Bikash Medhi; Kiran Marthak; Nirmala Rege; Tushar Garimella; Taruna Madan; Jagannath Kota; Ravi Shankar P. Singh; Gangadhar Sunkara; Manoj Jadhav; Nilima Kshirsagar; Deven Parmar展开收起
作者单位
1. Clinical Pharmacology & Quantitative Pharmacology Clinical Pharmacology & Safety Sciences R&D, AstraZeneca Waltham MA USA; 2. Quantitative Pharmacology and Pharmacometrics Merck & Co., Inc. Rahway NJ USA; 3. CSIR‐Institute of Genomics and Integrative Biology Delhi India; 4. Centre for Brain Research Indian Institute of Science Bengaluru India; 5. AOI Hospital Hyderabad India; 6. Clinical Sciences Oncology Takeda Biopharmaceuticals India Pvt. Ltd. Mumbai India; 7. Pharmazz India Private Limited Greater Noida India; 8. National Centre for Preclinical Reproductive and Genetic Toxicology ICMR‐National Institute for Research in Reproductive and Child Health Jehangir Merwanji Street Mumbai India; 9. Department of Pharmacology Narendra Modi Medical College Ahmedabad India; 10. VNS Group of Institutions Faculty of Pharmacy Bhopal India; 11. Department of Pharmacology Postgraduate Institute of Medical Education and Research (PGIMER) Chandigarh India; 12. Veeda Lifesciences Ahmedabad India; 13. Department of Pharmacology Era's Lucknow University, Lucknow India; 14. Daiichi Sankyo Inc. Baskin Ridge NJ USA; 15. Development Research, Indian Council of Medical Research, V. Ramalingaswami Bhawan New Delhi India; 16. Novartis Healthcare Private Limited Salarpuria Sattva Knowledge City Hyderabad India; 17. Clinical Pharmacology Group Lead Pfizer Inc. Cambridge MA USA; 18. Novartis Pharmaceuticals East Hanover NJ USA; 19. ISHA Therapeutics Hillsborough NJ USA; 20. National Academy of Medical Sciences, New Delhi Maharashtra University of Health Sciences,Nashik,422004 India; 21. Clinical RnD Zydus Therapeutics Inc. 73C Route 31N Pennington NJ USA展开收起
169
天
Development and Evaluation of a Population Pharmacokinetic Model for High‐Dose Methotrexate in Japanese Pediatric Patients with Acute Lymphoblastic Leukemia
作者
Takuya Suzuoka; Tsubura Noda; Kota Tsuge; Yasuyoshi Ishiwata; Toshinori Hirai; Takeshi Isoda; Masatoshi Takagi; Masashi Nagata展开收起
作者单位
1. Department of Pharmacy Institute of Science Tokyo Hospital Tokyo Japan; 2. Department of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences Institute of Science Tokyo Tokyo Japan展开收起
65
天
Population Pharmacokinetics and Exposure–Response of Sasanlimab, a Checkpoint Inhibitor, in Patients with Non‐Muscle Invasive Bladder Cancer and Other Solid Tumors
作者
Joanna C. Masters; Brian Jermain; Alan Liu; Rossano Cesari; Anna Maria Calella; Elisabete Michelon; Caimiao Wei; Susana Liu; Joseph Piscitelli展开收起
作者单位
1. Pfizer Inc. San Diego CA USA; 2. Pfizer Inc. New York NY USA; 3. Pfizer SRL Milan Italy; 4. Pfizer SRL Rome Italy; 5. Pfizer Inc. Quebec Canada展开收起
97
天
The Rise of the Digital Health Technology–AI Coupled System in the AI Era of Drug Development
作者
Hanrui Zhang; Gabriel K. Innes; Jonas Santiago; Ayoub Suliman; Norah Xiao; Hao Zhu; Dianne Paraoan; Jeffery Siegel; Yutao Gong; Ruihao Huang; Menglun Wang; Lixia Zhang; Qi Liu展开收起
作者单位
1. Office of Clinical Pharmacology Office of Translational Sciences, Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring MD USA; 2. Office of Medical Policy, Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring MD USA; 3. Office of Drug Evaluation Sciences Office of New Drugs, Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring MD USA展开收起
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
